Breaking News Instant updates and real-time market news.

MDLA

Medallia

$39.40

1.85 (4.93%)

09:01
08/13/19
08/13
09:01
08/13/19
09:01

Medallia initiated with an Outperform at William Blair

William Blair analyst Bhavan Suri initiated coverage of Medallia with an Outperform saying has a large addressable market. Medallia pioneered an emerging category of modern Experience Management solutions with a platform that is able to capture data from any source at massive scale and provide a real-time, 360-degree view of the daily journeys of customers and employees, Suri tells investors in a research note. He pegs the opportunity at $30.3B, implying Medallia has achieved roughly 1% penetration.

MDLA Medallia
$39.40

1.85 (4.93%)

08/13/19
OPCO
08/13/19
INITIATION
Target $55
OPCO
Outperform
Medallia initiated with an Outperform at Oppenheimer
Oppenheimer analyst Brian Schwartz started coverage of Medallia with an Outperform rating and a $55 price target. The analyst believes Medallia stands out from almost any pack as the pioneer of the experience management movement, and has "blossomed into a true platform success story of substantial scale with an accelerating subscription revenue growth trajectory." Schwartz is confident in Medallia's multi-year growth potential and its business momentum.
08/13/19
NEED
08/13/19
INITIATION
Target $45
NEED
Buy
Medallia initiated with a Buy at Needham
Needham analyst Scott Berg initiated Medallia with a Buy rating and a price target of $45, saying the company offers investors a "unique access" to the "rapidly growing" Experience Management Enterprise Software market. The analyst cites Medallia's "industry-leading platform" and a "seasoned" management team, forecasting the company's FY20 and FY21 revenue growth rates to be sustainable following the 20% rise in FY19. Berg adds that his price target assumes a 14.5-times expected FY21 revenue multiple, as the company's "highly profitable" long-term model justifies a premium valuation.
08/13/19
WELS
08/13/19
INITIATION
Target $45
WELS
Outperform
Medallia initiated with an Outperform at Wells Fargo
Wells Fargo analyst Philip Winslow started coverage of Medallia with an Outperform rating and a $45 price target. Because of its enterprise-grade SaaS platform, expanding product portfolio, and "highly engaged" user base that rivals the usage levels of social networks, the analyst views Medallia as well positioned to continue to maintain a leading position in the large and growing experience management market, enabling the company to deliver "significant growth" for multiple years.
08/13/19
ROTH
08/13/19
INITIATION
Target $52
ROTH
Buy
Medallia initiated with a Buy at Roth Capital
Roth Capital analyst Richard Baldry started coverage of Medallia with a Buy rating and a $52 price target. Already dominant in supporting enterprise clients in the Customer Experience Management sector, the analyst believes Medallia should be able to increase share in the mid-market while also expanding its product suite to support accelerated growth for at least three-to-five years.

TODAY'S FREE FLY STORIES

TELL

Tellurian

$9.04

0.75 (9.05%)

13:25
08/22/19
08/22
13:25
08/22/19
13:25
Options
Tellurian call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:25
08/22/19
08/22
13:25
08/22/19
13:25
General news
Treasury's $7 B 30-year TIPS reopening was well received »

Treasury's $7 B…

13:21
08/22/19
08/22
13:21
08/22/19
13:21
General news
30-Yr TIPS Auction Bid/Cover data reported »

30-Yr TIPS Auction…

13:21
08/22/19
08/22
13:21
08/22/19
13:21
General news
30-Yr TIPS Auction Total Amount data reported »

30-Yr TIPS Auction Total…

NTRA

Natera

$30.66

0.25 (0.82%)

13:18
08/22/19
08/22
13:18
08/22/19
13:18
Hot Stocks
Natera reports 'positive' local coverage determination issued by Palmetto MolDX »

Natera announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
08/22/19
08/22
13:17
08/22/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
08/22/19
08/22
13:16
08/22/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
08/22/19
08/22
13:15
08/22/19
13:15
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

NTRA

Natera

$30.53

0.12 (0.39%)

13:13
08/22/19
08/22
13:13
08/22/19
13:13
Recommendations
Natera analyst commentary  »

Piper says Natera gets…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

13:10
08/22/19
08/22
13:10
08/22/19
13:10
General news
FX Action: USD-CAD »

FX Action: USD-CAD peaked…

AMGN

Amgen

$204.16

0.32 (0.16%)

13:06
08/22/19
08/22
13:06
08/22/19
13:06
Hot Stocks
Amgen granted orphan designation for multiple myeloma treatment »

Amgen was granted orphan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 16

    Sep

  • 19

    Sep

ZIOP

Ziopharm

$5.09

-0.06 (-1.17%)

13:05
08/22/19
08/22
13:05
08/22/19
13:05
Options
Ziopharm call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 12

    Sep

SNY

Sanofi

$42.69

-0.48 (-1.11%)

13:04
08/22/19
08/22
13:04
08/22/19
13:04
Hot Stocks
Sanofi treatment of systemic sclerosis granted orphan designation »

Sanofi U.S. Service was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 16

    Sep

  • 23

    Sep

  • 02

    Oct

WFC

Wells Fargo

$45.62

0.63 (1.40%)

13:03
08/22/19
08/22
13:03
08/22/19
13:03
Periodicals
Wells Fargo to pay $6.5M to Navajo Nation to settle account suit, Reuters says »

Wells Fargo intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 12

    Oct

  • 15

    Oct

  • 27

    Oct

ILMN

Illumina

$288.00

-2.5 (-0.86%)

13:02
08/22/19
08/22
13:02
08/22/19
13:02
Hot Stocks
Illumina granted orphan designation neuroblastoma management diagnostic »

Illumina…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Sep

OSTK

Overstock.com

$21.84

2.34 (12.00%)

12:49
08/22/19
08/22
12:49
08/22/19
12:49
Hot Stocks
Breaking Hot Stocks news story on Overstock.com »

Overstock.com trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSTK

Overstock.com

$21.40

1.9 (9.74%)

12:45
08/22/19
08/22
12:45
08/22/19
12:45
Options
Overstock com call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$203.13

-0.71 (-0.35%)

, ALXN

Alexion

$118.04

3.17 (2.76%)

12:43
08/22/19
08/22
12:43
08/22/19
12:43
Recommendations
Amgen, Alexion analyst commentary at Piper Jaffray »

Piper Jaffray says Amgen…

AMGN

Amgen

$203.13

-0.71 (-0.35%)

ALXN

Alexion

$118.04

3.17 (2.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 16

    Sep

  • 19

    Sep

  • 02

    Oct

  • 19

    Oct

12:40
08/22/19
08/22
12:40
08/22/19
12:40
General news
Fed funds futures are lower after the hawkish comments »

Fed funds futures are…

ADM

Archer Daniels

$37.93

0.23 (0.61%)

, REGI

Renewable Energy

$11.27

0.42 (3.87%)

12:38
08/22/19
08/22
12:38
08/22/19
12:38
Periodicals
Trump to discuss biofuels with USDA, EPA officials, Reuters reports »

President Donald Trump is…

ADM

Archer Daniels

$37.93

0.23 (0.61%)

REGI

Renewable Energy

$11.27

0.42 (3.87%)

GPRE

Green Plains

$8.03

0.15 (1.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

OSTK

Overstock.com

$19.54

0.04 (0.21%)

12:33
08/22/19
08/22
12:33
08/22/19
12:33
Hot Stocks
Byrne says Overstock's blockchain keiretsu will revolutionize the world »

In a letter to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSTK

Overstock.com

$19.54

0.04 (0.21%)

12:30
08/22/19
08/22
12:30
08/22/19
12:30
Hot Stocks
Breaking Hot Stocks news story on Overstock.com »

Overstock com trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$292.12

-0.28 (-0.10%)

, SPX

S&P 500

$0.00

(0.00%)

12:29
08/22/19
08/22
12:29
08/22/19
12:29
General News
Canada still against Russia's return to G8, Reuters says »

Canada's government…

SPY

SPDR S&P 500 ETF Trust

$292.12

-0.28 (-0.10%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$292.07

-0.335 (-0.11%)

, SPX

S&P 500

$0.00

(0.00%)

12:28
08/22/19
08/22
12:28
08/22/19
12:28
General News
Ukraine, EU rebuff Trump's suggestion of admitting Russia to G7, Reuters says »

Ukraine's President…

SPY

SPDR S&P 500 ETF Trust

$292.07

-0.335 (-0.11%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$181.29

-2.27 (-1.24%)

, SNAP

Snap

$16.24

0.1 (0.62%)

12:27
08/22/19
08/22
12:27
08/22/19
12:27
Periodicals
Gun sellers allegedly used Snapchat to sell illegal guns, Guardian says »

Darwin BondGraham, a…

FB

Facebook

$181.29

-2.27 (-1.24%)

SNAP

Snap

$16.24

0.1 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 24

    Sep

  • 27

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.